ArticleMalaria journal2019

Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).

Jaishree Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.